Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction

被引:50
作者
Filicori, M [1 ]
Cognigni, GE [1 ]
机构
[1] Univ Bologna, Ctr Reprod Endocrinol, I-40138 Bologna, Italy
关键词
D O I
10.1210/jc.86.4.1437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although FSH is universally recognized as the key driver of ovarian follicle growth and maturation, the role of LH in these processes is more controversial. LH acts on theca cells to induce androgen substrate for estrogen conversion by the aromatase system; furthermore, LH can affect granulosa cell function starting in the midfollicular phase, when these cells express LH receptors. The capacity of LH to stimulate granulosa cells in larger follicles (> 10 mm diameter) may be the critical mechanism involved in the selection of the dominant follicle in the normal menstrual cycle. Furthermore, the addition of LH activity can shorten and optimize FSH ovulation induction and reduce the development of smaller preovulatory ovarian follicles that are associated with the severe complications of this procedure. Novel mixed gonadotropin administration regimens that incorporate graded amounts of LH and FSH activity may improve efficacy, safety, and cost of ovulation induction, particularly in the area of assisted reproduction.
引用
收藏
页码:1437 / 1441
页数:5
相关论文
共 52 条
[1]   An 'epidemic' of severe OHSS: a price we have to pay? [J].
Abramov, Y ;
Elchalal, U ;
Schenker, JG .
HUMAN REPRODUCTION, 1999, 14 (09) :2181-2183
[2]  
ADASHI EY, 1996, REPROD ENDOCRINOLOGY, P7
[3]   Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis [J].
Agrawal, R ;
Holmes, J ;
Jacobs, HS .
FERTILITY AND STERILITY, 2000, 73 (02) :338-343
[4]  
ANDERSON RE, 1989, FERTIL STERIL, V52, P216
[5]  
[Anonymous], 1998, J Clin Endocrinol Metab, V83, P1507
[6]  
[Anonymous], 2000, Hum Reprod, V15, P1446
[7]  
ARGUINZONIZ M, 2000, 15 ANN M EUR SOC HUM, P70
[8]   Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome [J].
Benadiva, CA ;
Davis, O ;
Kligman, I ;
Moomjy, M ;
Liu, HC ;
Rosenwaks, Z .
FERTILITY AND STERILITY, 1997, 67 (04) :724-727
[9]  
BENAMOR AF, 2000, 15 ANN M EUR SOC HUM, P46
[10]  
Borm G, 2000, HUM REPROD, V15, P1490